PDCD1 and neoplasm: By measuring multiple transcripts simultaneously, RNA-seq is well suited to characterize the functional state of immune cells in the tumor microenvironment for biomarkers of antigen presentation, IFN-γ signaling, T-cell active cytokines and other biological features that are responsive to PD-1 checkpoint blockade.